PCI Biotech Holding ASA (OSL:PCIB)
Norway · Delayed Price · Currency is NOK 0.2980
-0.0180 (-5.70%)
Oct 24, 2025, 3:34 PM CET
PCI Biotech Holding ASA Market Cap
PCI Biotech Holding ASA has a market cap or net worth of 11.16 million as of October 24, 2025. Its market cap has decreased by -82.56% in one year.
Market Cap
11.16M
Enterprise Value
-2.17M
Revenue
4.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.30
Market Cap Chart
Since June 23, 2008, PCI Biotech Holding ASA's market cap has decreased from 97.50M to 11.16M, a decrease of -88.55%. That is a compound annual growth rate of -11.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2025 | 11.80M | -73.40% |
| Dec 30, 2024 | 44.34M | -43.29% |
| Dec 29, 2023 | 78.20M | 2.20% |
| Dec 30, 2022 | 76.52M | -85.26% |
| Dec 30, 2021 | 519.21M | -50.14% |
| Dec 30, 2020 | 1.04B | -63.57% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.40B |
| Nordhealth AS | 2.83B |
| ArcticZymes Technologies ASA | 1.53B |
| Photocure ASA | 1.40B |
| Thor Medical ASA | 1.23B |
| Omda AS | 972.06M |
| Vistin Pharma ASA | 962.28M |
| Gentian Diagnostics ASA | 848.23M |